SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-044625
Filing Date
2018-02-14
Accepted
2018-02-14 10:52:03
Documents
1
Group Members
EDWIN M. KANIA, JR.FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLCFLAGSHIP VENTURES FUND IV, L.P.FLAGSHIP VENTURES GENERAL PARTNER LLCNOUBAR B. AFEYAN, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d529442dsc13ga.htm SC 13G/A 101621
  Complete submission text file 0001193125-18-044625.txt   103277
Mailing Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund 2004 L P (Filed by) CIK: 0001299790 (see all company filings)

IRS No.: 201399649
Type: SC 13G/A

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88541 | Film No.: 18608691
SIC: 3841 Surgical & Medical Instruments & Apparatus